Literature DB >> 19118518

Environmental tobacco smoke effects on lung surfactant film organization.

Patrick C Stenger1, Coralie Alonso, Joseph A Zasadzinski, Alan J Waring, Chun-Ling Jung, Kent E Pinkerton.   

Abstract

Adsorption of the clinical lung surfactants (LS) Curosurf or Survanta from aqueous suspension to the air-water interface progresses from multi-bilayer aggregates through multilayer films to a coexistence between multilayer and monolayer domains. Exposure to environmental tobacco smoke (ETS) alters this progression as shown by Langmuir isotherms, fluorescence microscopy and atomic force microscopy (AFM). After 12 h of LS exposure to ETS, AFM images of Langmuir-Blodgett deposited films show that ETS reduces the amount of material near the interface and alters how surfactant is removed from the interface during compression. For Curosurf, ETS prevents refining of the film composition during cycling; this leads to higher minimum surface tensions. ETS also changes the morphology of the Curosurf film by reducing the size of condensed phase domains from 8-12 microm to approximately 2 microm, suggesting a decrease in the line tension between the domains. The minimum surface tension and morphology of the Survanta film are less impacted by ETS exposure, although the amount of material associated with the film is reduced in a similar way to Curosurf. Fluorescence and mass spectra of Survanta dispersions containing native bovine SP-B treated with ETS indicate the oxidative degradation of protein aromatic amino acid residue side chains. Native bovine SP-C isolated from ETS exposed Survanta had changes in molecular mass consistent with deacylation of the lipoprotein. Fourier Transform Infrared Spectroscopy (FTIR) characterization of the hydrophobic proteins from ETS treated Survanta dispersions show significant changes in the conformation of SP-B and SP-C that correlate with the altered surface activity and morphology of the lipid-protein film.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19118518      PMCID: PMC2637945          DOI: 10.1016/j.bbamem.2008.11.021

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  68 in total

1.  Metastability of a supercompressed fluid monolayer.

Authors:  Ethan C Smith; Jonathan M Crane; Ted G Laderas; Stephen B Hall
Journal:  Biophys J       Date:  2003-11       Impact factor: 4.033

2.  A comparative study of mechanisms of surfactant inhibition.

Authors:  Lasantha Gunasekara; W Michael Schoel; Samuel Schürch; Matthias W Amrein
Journal:  Biochim Biophys Acta       Date:  2007-11-06

3.  Domain shapes and patterns: the phenomenology of modulated phases.

Authors:  M Seul; D Andelman
Journal:  Science       Date:  1995-01-27       Impact factor: 47.728

Review 4.  Toxic oxidant species and their impact on the pulmonary surfactant system.

Authors:  E Putman; L M van Golde; H P Haagsman
Journal:  Lung       Date:  1997       Impact factor: 2.584

5.  Modifying calf lung surfactant by hexadecanol.

Authors:  Coralie Alonso; Frank Bringezu; Gerald Brezesinski; Alan J Waring; Joseph A Zasadzinski
Journal:  Langmuir       Date:  2005-02-01       Impact factor: 3.882

6.  Conformational mapping of the N-terminal segment of surfactant protein B in lipid using 13C-enhanced Fourier transform infrared spectroscopy.

Authors:  L M Gordon; K Y Lee; M M Lipp; J A Zasadzinski; F J Walther; M A Sherman; A J Waring
Journal:  J Pept Res       Date:  2000-04

7.  Synchrotron X-ray study of lung surfactant-specific protein SP-B in lipid monolayers.

Authors:  K Y Lee; J Majewski; T L Kuhl; P B Howes; K Kjaer; M M Lipp; A J Waring; J A Zasadzinski; G S Smith
Journal:  Biophys J       Date:  2001-07       Impact factor: 4.033

8.  Effects of maternal smoking during pregnancy and environmental tobacco smoke on asthma and wheezing in children.

Authors:  F D Gilliland; Y F Li; J M Peters
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

9.  Atomic force microscopy studies of functional and dysfunctional pulmonary surfactant films, II: albumin-inhibited pulmonary surfactant films and the effect of SP-A.

Authors:  Yi Y Zuo; Seyed M Tadayyon; Eleonora Keating; Lin Zhao; Ruud A W Veldhuizen; Nils O Petersen; Matthias W Amrein; Fred Possmayer
Journal:  Biophys J       Date:  2008-06-06       Impact factor: 4.033

Review 10.  Structure and properties of surfactant protein C.

Authors:  J Johansson
Journal:  Biochim Biophys Acta       Date:  1998-11-19
View more
  10 in total

1.  Lipid-protein interactions alter line tensions and domain size distributions in lung surfactant monolayers.

Authors:  Prajnaparamita Dhar; Elizabeth Eck; Jacob N Israelachvili; Dong Woog Lee; Younjin Min; Arun Ramachandran; Alan J Waring; Joseph A Zasadzinski
Journal:  Biophys J       Date:  2012-01-03       Impact factor: 4.033

2.  Glycerol-induced membrane stiffening: the role of viscous fluid adlayers.

Authors:  Luka Pocivavsek; Kseniya Gavrilov; Kathleen D Cao; Eva Y Chi; Dongxu Li; Binhua Lin; Mati Meron; Jaroslaw Majewski; Ka Yee C Lee
Journal:  Biophys J       Date:  2011-07-06       Impact factor: 4.033

Review 3.  Overcoming rapid inactivation of lung surfactant: analogies between competitive adsorption and colloid stability.

Authors:  Joseph A Zasadzinski; Patrick C Stenger; Ian Shieh; Prajna Dhar
Journal:  Biochim Biophys Acta       Date:  2009-12-22

4.  Electronic cigarette vapor alters the lateral structure but not tensiometric properties of calf lung surfactant.

Authors:  Rebecca J Przybyla; Jason Wright; Rajan Parthiban; Saeed Nazemidashtarjandi; Savas Kaya; Amir M Farnoud
Journal:  Respir Res       Date:  2017-11-17

5.  Structural and functional stability of the sulfur-free surfactant protein B peptide mimic B-YL in synthetic surfactant lipids.

Authors:  Frans J Walther; Shantanu Sharma; Larry M Gordon; Alan J Waring
Journal:  BMC Pulm Med       Date:  2021-10-22       Impact factor: 3.317

6.  Evaluating the Impact of Hydrophobic Silicon Dioxide in the Interfacial Properties of Lung Surfactant Films.

Authors:  Eduardo Guzmán; Eva Santini; Michele Ferrari; Libero Liggieri; Francesca Ravera
Journal:  Environ Sci Technol       Date:  2022-01-25       Impact factor: 11.357

7.  Critical structural and functional roles for the N-terminal insertion sequence in surfactant protein B analogs.

Authors:  Frans J Walther; Alan J Waring; Jose M Hernandez-Juviel; Larry M Gordon; Zhengdong Wang; Chun-Ling Jung; Piotr Ruchala; Andrew P Clark; Wesley M Smith; Shantanu Sharma; Robert H Notter
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

8.  Heterozygosity for E292V in ABCA3, lung function and COPD in 64,000 individuals.

Authors:  Marie Bækvad-Hansen; Børge G Nordestgaard; Morten Dahl
Journal:  Respir Res       Date:  2012-08-06

Review 9.  Dysregulated Cell Signaling in Pulmonary Emphysema.

Authors:  Chih-Ru Lin; Karim Bahmed; Beata Kosmider
Journal:  Front Med (Lausanne)       Date:  2022-01-03

10.  An adverse outcome pathway for lung surfactant function inhibition leading to decreased lung function.

Authors:  Emilie Da Silva; Ulla Vogel; Karin S Hougaard; Jesus Pérez-Gil; Yi Y Zuo; Jorid B Sørli
Journal:  Curr Res Toxicol       Date:  2021-05-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.